Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 12/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28432429 | 1.00 | HMGCR (0.46) | HMGCR | |
| SCHEMBL19524874 | 1.00 | HMGCR (0.46) | HMGCR | |
| SCHEMBL1978777 | 0.94 | HMGCR (0.48) | HMGCR | |
| SCHEMBL2050591 | 0.92 | HMGCR (0.46) | HMGCR | |
| SCHEMBL2034579 | 0.92 | HMGCR (0.46) | HMGCR | |
| SCHEMBL4451033 | 0.92 | HMGCR (0.48) | HMGCR | |
| SCHEMBL4453080 | 0.92 | HMGCR (0.48) | HMGCR | |
| SCHEMBL14189834 | 0.90 | HMGCR (0.48) | HMGCR | |
| SCHEMBL12198701 | 0.89 | HMGCR (0.53) | HMGCR | |
| SCHEMBL4453107 | 0.88 | HMGCR (0.49) | HMGCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9926283-B2 | Intermediate compound for preparing rosuvastatin calcium and method for preparing rosuvastatin calcium therefrom | ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. (CN) | 2018-03-27 | — | — | US | disclosed |
| US-9926283-B2 | Intermediate compound for preparing rosuvastatin calcium and method for preparing rosuvastatin calcium therefrom | ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. (CN) | 2018-03-27 | — | — | US | disclosed |
| EP-3115367-B1 | INTERMEDIATE COMPOUND FOR PREPARING ROSUVASTATIN CALCIUM AND METHOD FOR PREPARING ROSUVASTATIN CALCIUM THEREFROM | ASYMCHEM LABORATORIES (TIANJIN) CO LTD (CN) | 2017-11-01 | — | — | EP | disclosed |
| US-20170022169-A1 | INTERMEDIATE COMPOUND FOR PREPARING ROSUVASTATIN CALCIUM AND METHOD FOR PREPARING ROSUVASTATIN CALCIUM THEREFROM | ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. (CN) | 2017-01-26 | — | — | US | disclosed |
| US-20170022169-A1 | INTERMEDIATE COMPOUND FOR PREPARING ROSUVASTATIN CALCIUM AND METHOD FOR PREPARING ROSUVASTATIN CALCIUM THEREFROM | ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. (CN) | 2017-01-26 | — | — | US | disclosed |
| EP-3115367-A1 | INTERMEDIATE COMPOUND FOR PREPARING ROSUVASTATIN CALCIUM AND METHOD FOR PREPARING ROSUVASTATIN CALCIUM THEREFROM | Asymchem Laboratories (Tianjin) Co., Ltd. (CN) | 2017-01-11 | — | — | EP | disclosed |
| WO-2015131405-A1 | INTERMEDIATE COMPOUND FOR PREPARING ROSUVASTATIN CALCIUM AND METHOD FOR PREPARING ROSUVASTATIN CALCIUM THEREFROM | 凯莱英医药集团（天津）股份有限公司 | 2015-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170022169-A1 | INTERMEDIATE COMPOUND FOR PREPARING ROSUVASTATIN CALCIUM AND METHOD FOR PREPARING ROSUVASTATIN CALCIUM THEREFROM | HMGCR, REN, PCSK9 | HMGCR 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.